Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists

James B Morris1, Bronwyn Kenney, Huy Huynh

  • 1Cellular Biochemistry Laboratory, Baker Heart Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne 8009, Victoria, Australia.

Endocrinology
|July 16, 2005
PubMed

Insights

Forkhead box protein 1 (FOXO1) is active in heart cells and can promote apoptosis. Phenylephrine increases FOXO1 expression and nuclear localization, enhancing its pro-apoptotic function in cardiomyocytes.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cell Biology
  • Signaling Pathways

Background:

  • Cardiomyocyte apoptosis is regulated by protein kinase Akt, which can suppress cell death.
  • Akt phosphorylates forkhead box (FOXO) transcription factors, inhibiting their pro-apoptotic activity.
  • The role of FOXO1 in cardiomyocyte apoptosis was investigated.

Purpose of the Study:

  • To determine if FOXO1 is expressed, regulated, and functional in cardiomyocytes.
  • To investigate the effects of epidermal growth factor (EGF) and phenylephrine on FOXO1 activity.
  • To understand FOXO1's contribution to cardiomyocyte apoptosis.

Main Methods:

  • Neonatal rat cardiomyocytes were treated with EGF and phenylephrine.
  • Akt and FOXO1 phosphorylation, expression, and subcellular localization were assessed.
  • Reporter gene assays were used to measure FOXO1 transcriptional activity.
  • FOXO1's role in apoptosis was evaluated.

Main Results:

  • EGF rapidly phosphorylated Akt and slowly phosphorylated FOXO1.
  • Phenylephrine did not phosphorylate Akt but caused FOXO1 dephosphorylation and increased its expression.
  • Phenylephrine induced nuclear translocation of FOXO1, unlike EGF.
  • Overexpressed FOXO1 activated the pro-apoptotic TNFalpha-related apoptosis-inducing ligand, an effect modulated by EGF and phenylephrine.

Conclusions:

  • FOXO1 is expressed, regulated, and functionally active in cardiomyocytes.
  • Phenylephrine promotes FOXO1 activity and nuclear localization, potentially increasing apoptosis.
  • FOXO1 may play a significant role in mediating apoptotic responses in the heart.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...